Skip to content
Search

Latest Stories

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and recycling initiative. NHS Trusts and community pharmacies participating in the new scheme will have specialised recycling containers for inhalers installed to simplify public participation, Grundon said in a statement.

Inhalers alone contribute to 4 per cent of NHS CO2 emissions, with around 73 million dispensed annually. By 2026, the health service aims to achieve a 50 per cent reduction in carbon emissions from waste management, a target that rises to 80 percent between 2028 and 2032, as outlined in the NHS Clinical Waste Strategy.


"This scheme holds the potential to revolutionise the approach of NHS Trusts towards achieving heightened carbon savings and ultimately, net zero emissions," said Chris Edwards, Grundon’s General Manager – Technical. "Each discarded pressurised Metered Dose Inhaler (pMDI) contains highly polluting hydrofluorocarbon (HFC) gases - a category of greenhouse gas known to be over a thousand times more detrimental than carbon dioxide in driving climate change.”

“This initiative securely captures these gases and repurposes them for application in the refrigeration sector. By also recycling the plastic and aluminium components of the device, we are making a noteworthy contribution to the circular economy,” he added.

Once collected, these will undergo processing at Grundon’s specialist recycling facility in Ewelme, Oxfordshire, which is capable of handling more than 200,000 inhalers a day. The company aims to recycle 80 per cent of all prescribed inhalers by 2025, the statement added.

After successful trials with several NHS Trusts and Health Boards in England and Wales, the return and recycling service is now being rolled out nationwide, the company said. Swansea Bay University Health Board (SBUHB) joined in February, initiating a pilot take-back project for inhaler recycling across eight pharmacies. This involved using patient education and promotional materials to encourage individuals to return used or unwanted inhalers to their pharmacy.

"We're the first in Wales to lead on an inhaler recycling project like this," said Oliver Newman, Assistant Divisional Manager, Pharmacy & Medicines Management at SBUHB. "With a favorable uptake, we aim to expand the scheme across our health board. The Inhaler Recycling Pilot Project utilized funding from the Welsh Government to establish the contract with Grundon."

Grundon's inhaler recycling technology has been employed in two prior pharmaceutical-led projects. The "Take AIR" (Action for Inhaler Recycling) initiative was funded by Chiesi and received support from University Hospitals of Leicester NHS Trust (UHL) and Leicestershire and Rutland Local Pharmaceutical Committee (LPC).

Operational from February 2021 to February 2023, the program facilitated the return of 52,148 inhalers by mail within a two-year span. It is estimated to have prevented approximately 305.3 tonnes of carbon dioxide emissions from being released into the atmosphere.

Grundon worked with GSK on the Complete the Cycle inhaler recycling program, which operated for nearly a decade. In 2018, over 3 million inhalers were recycled, resulting in CO2 emissions savings equivalent to removing 16,174 cars from UK roads for that year.

In May, NHS England tasked the Royal Pharmaceutical Society with creating guidance to assist community and hospital pharmacy teams throughout Britain in minimising the environmental footprint of pharmacy services, pharmaceutical care, and medicines. Medicines contribute to 25 per cent of the NHS's carbon emissions, and this initiative is aligned with the NHS's target of achieving 'net zero' emissions by 2040.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less